Familial hypertrophic cardiomyopathy: From mutations to functional defects

Circulation Research

Volumn 83, Issue 6, 1998, Pages 580-593

  Bonne, Gisèle ^a   Carrier, Lucie ^a   Richard, Pascale ^a   Hainque, Bernard ^a   Schwartz, Ketty ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Alteration in cardiac contractility; Familial hypertrophic cardiomyopathy; Genetic mutation; Mouse model; Sarcomeric protein

Indexed keywords

MYOSIN HEAVY CHAIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

ANIMAL MODEL; AUTOSOMAL DOMINANT DISORDER; CARDIOMYOPATHY; FAMILIAL DISEASE; GENE MUTATION; GENOTYPE; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SARCOMERE;

EID: 0032555955     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.6.580     Document Type: Review

References (144)

1. Vulpian A. Contribution à l'étude des rétrécissements de l'orifice ventriculo-aortique. Arch Physiol. 1868;3:220-222.
2. Wiglc ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis. 1985; 28:1-83.
3. Maron BJ, Bonow RO, Cannon RO, Leon MB. Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316:780-789 and 844-852.
4. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation. 1995;93:841-842.
5. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995;92:785-789.
6. Hollman A, Goodwin JF, Teare D, Renwick JW. A family with obstructive cardiomyopathy (asymmetrical hypertrophy). Br Heart J. 1960;22:449-456.
7. MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins HC, Anan R, Thierfelder LH, McGarry K, Rowland E, McKenna WJ, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest. 1995;96:1216-1220.
8. Rayment I, Rypniewski WR, Schmidt-Bäse K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 1993;261:50-56.
9. Schiaffino S. Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev. 1996;76: 371-423.
10. 2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol. 1991;97: 1141-1163.
11. Weisberg A, Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci U S A. 1996;93:8999-9003.
12. Dennis JE, Shimizu T, Reinach FC, Fischman DA. Localization of C-protein isoforms in chicken skeletal muscle: ultrastructure detection using monoclonal antibodies. J Cell Biol. 1984;98:1514-1522.
13. Gulick J, Hewett TE, Klevitsky R, Buck SH, Moss RL, Robbins J. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res. 1997;80:655-664.
14. Mercadier JJ, Bouveret P, Gorza L, Schiaffino S, Clark WA, Zak R, Swynghedauw B, Schwartz K. Myosin isoenzymes in normal and hypertrophied human myocardium. Circ Res. 1983;53:52-62.
15. Gorza L, Mercadier JJ, Schwartz K, Thornell LE, Sartore S, Schiaffino S. Myosin types in the human heart: an immunofluorescence study of normal and hypertrophied atrial and ventricular myocardium. Circ Res. 1984;54:694-702.
16. Saez L, Gianola K, McNally E, Feghali R, Eddy R, Shows T, Leinwand L. Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res. 1987;15:5443-5459.
17. Matsuoka R, Yoshida MC, Kanda N, Kimura M, Ozasa H, Takao A. Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2-q13. Am J Med Genet. 1989;32:279-284.
18. Jaenicke T, Diederich KW, Haas W, Schleich J, Lichter P, Pfordt M, Bach A, Vosberg HP. The complete sequence of the human β-myosin heavy chain gene and an analysis of its product. Genomics. 1990;8: 194-206.
19. Liew CC, Sole MJ, Yamauchi-Takihar K, Kellam B, Anderson DH, Lin L, Liew JC. Complete sequence and organization of the human cardiac β-myosin heavy chain gene. Nucleic Acids Res. 1990;18:3647-3651.
20. Sata M, Stafford WF, Mabuchi K, Ikebe M. The motor domain and the regulatory domain of myosin solely dictate enzymatic activity and phosphorylation-dependent regulation, respectively. Proc Natl Acad Sci U S A. 1997;94:91-96.
21. Fougerousse F, Dufour C, Roudaut C, Beckmann JS. Dinucleotide repeat polymorphism at the human gene for cardiac beta-myosin heavy chain (MYH7). Hum Mol Genet. 1992;1:64.
22. Schwartz K, Dufour C, Fougerousse F, Faure L, Carrier L, Hengstenberg C, Cambien F, Cohen D, Ferrière M, Desnos M, Sacrez A, Dubourg O, Komajda M. Exclusion of myosin heavy chain and cardiac actin gene involvement in hypertrophic cardiomyopathies of several French families. Circ Res. 1992;71:3-8.
23. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999-1006.
24. Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg HP, Seidman JG, Seidman CE. Molecular basis for familial hypertrophic cardiomyopathy: an α/β cardiac myosin heavy chain hybrid gene. Cell. 1990;62: 991-998.
25. Epstein ND, Cohn GM, Cyran F, Fananapazir L. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene: a 908 Leu>Val mutation and a 403 Arg>Gln mutation. Circulation. 1992;86:345-352.
26. Fananapazir L, Dalakas M, Cyran F, Cohn G, Epstein N. Central core disease is present in hypertrophic cardiomyopathy patients with distinct mutations in the beta myosin heavy chain gene [abstract]. Circulation. 1992;86(suppl I):I-229.
27. Harada H, Kimura A, Nishi H, Koga Y, Sasazuki Y, Toshima H. Genetic analysis of hypertrophic cardiomyopathy [abstract]. Circulation. 1992; 86(suppl I):I-591.
28. Marian AJ, Yu QT, Mares A, Hill R, Roberts R, Perryman MB. Detection of a new mutation in the β-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest. 1992;90: 2156-2165.
29. Nishi H, Kimura A, Harada H, Toshima H, Sasazaki T. Novel missense mutation in cardiac β-myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 1992;188:379-387.
30. Watkins H, Rosenzweig T, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristic and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1106-1114.
31. Cuda G, Fananapazir L, Zhu WS, Seller JR, Epstein NE. Skeletal muscle expression and abnormal function of β-myosin in hypertrophic cardiomyopathy. J Clin Invest. 1993;91:2861-2865.
32. Dausse E, Komajda M, Dubourg O, Fetler L, Dufour C, Carrier L, Wisnewski C, Bercovici J, Hengstenberg C, Al-Mahdawi S, Isnard R, Hagege A, Bouhour JB, Desnos M, Beckmann JS, Weissenbach J, Schwartz K, Guicheney P. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hot-spot for mutations in the β-myosin heavy chain gene. J Clin Invest. 1993;92:2807-2813.
33. Fananapazir L, Dalakas MD, Cyran F, Cohn G, Epstein ND. Missense mutations in the β myosin heavy chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 1993;90: 3993-3997.
34. Harada H, Kimura A, Nishi H, Sasazuki Y, Toshima H. A missense mutation of cardiac β-myosin heavy chain gene linked to familial hypertrophic cardiomyopathy in affected Japanese families. Biochem Biophys Res Commun. 1993;194:791-798.
35. Mares A, Greve G, Tapscott T, Roberts R. Screening and identification of known and novel mutations in hypertrophic cardiomyopathies based on molecular scanning with chemical cleavage [abstract]. Circulation. 1993;88(suppl I):I-572.
36. Nishi H, Kimura A, Matsumyama K, Koga Y, Sasazuki T, Toshima H. Two distinct mutations of cardiac β myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy [abstract]. Circulation. 1993;88(suppl I):I-343.
37. Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, Vecchio C, Shono H, Nakao S, Tanaka H, Mares A, Towbin JA, Spirito P, Roberts R, Seidman JG, Seidman CE. Prognostic implications of novel β myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest. 1994;93:280-285.
38. Consevage M, Salada GC, Baylen BG, Ladda RL, Rogan PK. A new missense mutation, Arg719Gln, in the β-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Hum Mol Genet. 1994;3:1025-1026.
39. Dufour C, Dausse E, Fetler L, Dubourg O, Bouhour JB, Vosberg HP, Guicheney P, Komajda M, Schwartz K. Identification of a mutation near a functional site of the β cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1994;9: 1241-1247.
40. Fananapazir L, Winkler J, Satorius O, Epstein N. Identification of β-myosin heavy chain gene mutations in 31 athletes with hypertrophic cardiomyopathy [abstract]. Circulation. 1994;90(suppl I):I-442.
41. Kimura A, Nishi H, Harada H, Noguchi M, Ashizawa N, Koga Y, Yano K, Yazaki Y, Kitabatake A, Toshima H, Sasazuki T. Genetic analysis of hypertrophic cardiomyopathy in Japan. In: Clark EB, Markward RR, Takao A, eds. Developmental Mechanisms of Heart Disease. New York, NY: Futura Publishing Co Inc; 1994:113-120.
42. Nishi H, Kimura A, Harada H, Adachi K, Koga Y, Sasazuki T, Toshima H. Possible gene dose effect of a mutant cardiac β-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 1994;200:549-556.
43. Toyo-oka T, Takazawa K, Kimura N, Inukai M, Wang YP. A novel mutation of myosin heavy chain gene from cardiac β to foetal skeletal type in a family with HCM, DCM and sudden death: a report and discussion [abstract]. Eur Heart J. 1994;15(suppl):334.
44. Arai S, Matsuoka R, Hirayama K, Sakurai H, Tamura M, Ozawa T, Kimura M, Imamura SI, Furutani Y, Joh-o K, Kawana M, Takao A, Hosoda S, Momma K. Missense mutation of the β-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy. Am J Med Genet. 1995;58:267-276.
45. Moolman JC, Brink PA, Corfield VA. Identification of a novel Ala797Thr mutation in exon 21 of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum Mutat. 1995;6:197-198.
46. Nakajima-Taniguchi C, Matsui H, Eguchi N, Nagata S, Kishimoto T, Yamauchi-Takihara K. A novel deletion mutation in the β-myosin heavy chain gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1995;27:2607-2612.
47. Nishi H, Kimura A, Harada H, Koga Y, Adachi K, Matsuyama K, Koyanagi T, Yasunaga S, Imaizumi T, Toshima H, Sasazuki T. A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation. 1995;91:2911-2915.
48. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND. Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 1995;92:3864-3868.
49. Kuang SQ, Yu JD, Lu L, He LM, Gong LS, Chen SJ, Chen Z. Identification of a novel missense mutation in the cardiac β-myosin chain gene in a Chinese patient with sporadic hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1996;28:1879-1883.
50. Rottbauer W, Grünig E, Brown B, Zehelein J, Schelfold T. A novel β-myosin mutation in a large family suffering from dilated and hypertrophic cardiomyopathy [abstract]. Circulation. 1996;94(suppl I):I-162.
51. Weist B, McKeown P, Uhl K, Vosberg HP. Candidate gene analysis of hypertrophic cardiomyopathy [abstract]. J Mol Cell Cardiol. 1996; 28:A44.
52. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne G, Guicheney P, Hainque B, Bouhour J, Mallet A, Feingold J, Schwartz K, Komajda M. Penetrance of familial hypertrophic cardiomyopathy. Genet Couns. 1997;8:107-114.
53. Hasenmaier B, Döhlemann C, Meitinger T, Vosberg HP. De novo mutations in the β-myosin gene causes hypertrophic cardiomyopathy [abstract]. J Mol Cell Cardiol. 1997;29:A46.
54. Barton PJR, Cohen A, Robert B, Fiszman MY, Bonhomme F, Guénet JL, Leader DP, Buckingham ME. The myosin alkali light chains of mouse ventricular and slow skeletal muscle are indistinguishable and are encoded by the same gene. J Biol Chem. 1985;260:8578-8584.
55. Kretsinger RH. Structure and evolution of calcium-modulated proteins. CRC Crit Rev Biochem. 1980;8:119-174.
56. Trybus KM. Role of myosin light chains. J Muscle Res Cell Motil. 1994;15:587-594.
57. Szent-Gyorgyi A, Szentkiralyi E. The light chains of scallop myosin as regulatory subunits. J Mol Biol. 1973;74:179-204.
58. Lowey S, Waller G, Trybus K. Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature. 1993;365: 454-456.
59. VanBuren P, Waller GS, Harris DE, Trybus KM, Warshaw DM, Lowey S. The essential light chain is required for full force production by skeletal muscle myosin. Proc Natl Acad Sci U S A. 1994;91: 12403-12407.
60. Morano I, Ritter O, Bonz A, Timek T, Vahl C, Michel G. Myosin light chain-actin interaction regulates cardiac contractility. Circ Res. 1995; 76:720-725.
61. Rarick HM, Opgenorth TJ, von Geldern TW, Wu-Wong JR, Solaro RJ. An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity. J Biol Chem. 1996;271: 27039-27043.
62. Fodor WL, Darras B, Seharaseyon J, Falkenthal S, Francke U, Vanin EF. Human ventricular/slow twitch myosin alkali light chain gene: characterization, sequence, and chromosomal location. J Biol Chem. 1989;264:2143-2149.
63. Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutation in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996; 13:63-69.
64. Sarkar S, Sreter FA, Gergely J. Light chains of myosins from white, red, and cardiac muscles. Proc Natl Acad Sci U S A. 1971;68:946-950.
65. Sweeney H, Bowman B, Stull J. Myosin light chains phosphorylation in striated muscle: regulation and function. Am J Physiol. 1993;264: C1085-C1095.
66. Chen J, Kubalak SW, Minamisawa S, Price RL, Becker KD, Hickey R, Ross JJ, Chien KR. Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem. 1998;273:1252-1256.
67. Macera MJ, Szabo P, Wadgaonkar R, Siddiqui MAQ, Verma RS. Localization of the gene encoding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23q24.3. Genomics. 1992;13: 765-772.
68. Flavigny J, Richard P, Isnard R, Carrier L, Charron P, Bonne G, Forissier JF, Desnos M, Dubourg O, Komajda M, Schwartz K, Hainque B. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med. 1998;76:208-214.
69. da Silva AC, Reinach FC. Calcium binding induces conformational changes in muscle regulatory proteins. Trends Biochem Sci. 1991;16: 53-57.
70. Anderson AAW, Greig A, Mark TM, Malouf NN, Oakeley AE, Ungerleider RM, Allen PD, Kay BK. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res. 1995;76:681-686.
71. Mesnard L, Logeart D, Taviaux S, Diriong S, Mercadier JJ, Samson F. Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart. Circ Res. 1995;76:687-692.
72. Townsend P, Barton P, Yacoub M, Farza H. Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J Mol Cell Cardiol. 1995;27:2223-2236.
73. Townsend PJ, Farza H, MacGeoch C, Spurr NK, Wade R, Gahlmann R, Yacoub MH, Barton PJR. Human cardiac troponin T: identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q. Genomics. 1994;21:311-316.
74. Jin JP, Huang QQ, Yen HI, Lin JJC. Complete nucleotide sequence and structural organization of rat cardiac troponin T gene: a single gene generates embryonic and adult isoforms via developmentally regulated alternative splicing. J Mol Biol. 1992;227:1269-1276.
75. Thierfelder L, Watkins H, MacRae C, Limas R, McKenna W, Vosberg HP, Seidman JC, Seidman CE. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701-712.
76. Forissier JF, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Fauré S, Dubourg O, Millaire A, Hagège A, Desnos M, Komajda M, Schwartz K. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation. 1996;94:3069-3073.
77. Zot AS, Potter JD. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophys Biophys Chem. 1987; 16:535-559.
78. Watkins H, McKenna WJ, Thierfelder L, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058-1064.
79. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman CE, Brink PA, Watkins H. Sudden death due to troponin T mutations. J Am Coll Cardiol. 1997;29:549-555.
80. Nakajima-Taniguchi C, Matsui H, Fujio Y, Nagata S, Kishimoto T, Yamauchi-Takihara K. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1997;29:839-843.
81. Hunkeler NM, Kullman J, Murphy AM. Troponin I isoform expression in human heart. Circ Res. 1991;69:1409-1414.
82. MacGeoch C, Barton PJR, Vallins WJ, Bhavsar P, Spurr NK. The human cardiac troponin I locus: assignment to chromosome 19p13.2-19q13.2. Hum Genet. 1991;88:101-104.
83. Bhavsar PK, Brand NJ, Yacoub MH, Barton PJR. Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics. 1996;35:11-23.
84. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 1997;16:379-382.
85. Solaro RJ, Van Eyk J. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol. 1996;28:217-230.
86. 2+-sensitivity of rat myofibrils. J Biol Chem. 1997;272:26887-26892.
87. Lees-Miller JP, Helfman DM. The molecular basis for tropomyosin isoform diversity. Bioessays. 1991;13:429-437.
88. Eyre H, Akkari PA, Wilton SD, Callen DC, Baker E, Laing NG. Assignment of the human skeletal muscle alpha-tropomyosin gene (TPM1) to band 15q22 by fluorescence in situ hybridization. Cytogenet Cell Genet. 1995;69:15-17.
89. Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi-Takihara K. Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1995;27:2053-2058.
90. Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H, Fujio T, Kunisada K, Nagata S, Kishimoto T. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the α-tropomyosin gene. Heart. 1996;76:63-65.
91. Coviello DA, Maron BJM, Spirito P, Watkins H, Vosberg HP, Thierfelder L, Schoen FJ, Seidman JG, Seidman CE. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol. 1997;29:635-640.
92. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann JS, Weissenbach J, Vosberg HP, Fiszman M, Komajda M, Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438-440.
93. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein C: a modulator of cardiac contraction? EMBO J. 1995;14:1952-1960.
94. Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagège AA, Trent RJ, Komajda M, Schwartz K. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 1997;80:427-434.
95. Fougerousse F, Delezoide AL, Fiszman MY, Schwartz K, Beckmann JS, Carrier L. Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development. Circ Res. 1998;82:130-133.
96. Gautel M, Fürst DO, Cocco A, Schiaffino S. Isoform transitions of the myosin-binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. Circ Res. 1998;82:124-129.
97. Bähler M, Moser H, Eppenberger HM, Walliman T. Heart C-protein is transiently expressed during skeletal muscle development in the embryo, but persists in cultured myogenic cells. Dev Biol. 1985;112:345-352.
98. Fürst DO, Vinkemeyer U, Weber K. Mammalian skeletal muscle C-protein: purification from bovine muscle, binding to titin and the characterization of a full-length cDNA. J Cell Sci. 1992;102:769-778.
99. Freiburg A, Gautel M. A molecular map of the interactions between titin and myosin-binding protein C: implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem. 1996;235: 317-326.
100. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
101. Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Fischer C, Vollrath B, Mall G, Dietz R, Kübler W, Katus HA. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy: characterization of cardiac transcript and protein. J Clin Invest. 1997;100:475-482.
102. Yu B, French JA, Carrier L, Jeremy RW, McTaggart DR, Nicholson MR, Hambly B, Semsarian C, Richmond DR, Schwartz K, Trent RJ. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the myosin binding protein C gene. J Med Genet. 1998; 35:205-210.
103. Moolman-Smook JC, Mayosi B, Brink P, Corfield VA. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. J Med Genet. 1998;35:253-254.
104. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-1257.
105. Sweeney HL, Straceski AJ, Leinwand LA, Tikunov BA, Faust L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem. 1994;269:1603-1605.
106. Bottinelli R, Coviello DA, Redwood CS, Pellegrino MA, Maron BJ, Spirito P, Watkins H, Reggiani C. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res. 1998;82:106-115.
107. Bejsovec A, Anderson P. Myosin heavy-chain mutations that disrupt caenorhabditis elegans thick filament assembly. Genes Dev. 1988;2: 1307-1317.
108. Bejsovec A, Anderson P. Functions of the myosin ATP and actin binding sites are required for C. elegans thick filament assembly. Cell. 1990;60:133-140.
109. Beall C, Sepanski MA, Fyrberg EA. Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles. Genes Dev. 1989;3:131-140.
110. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, Robbins J. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest. 1996;98:1906-1917.
111. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. J Clin Invest. 1996;98: 2456-2461.
112. Geisterfer-Lowrance AAT, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996;272:731-734.
113. Vikstrom KL, Factor SM, Leinwand LA. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med. 1996;2:556-567.
114. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, Mendelsohn ME. Electrophysiological abnormalities and arrhythmias in α MHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest. 1997;99:570-576.
115. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest. 1995;95:1409-1414.
116. Cuda G, Fananapazir L, Epstein ND, Sellers JR. The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil. 1997;18:275-283.
117. 92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ Res. 1997;81:76-85.
118. Marian AJ, Yu Q-T, Mann DL, Graham FL, Roberts R. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res. 1995;77:98-106.
119. Becker KD, Gottshall KR, Hickey R, Perriard JC, Chien KR. Point mutations in human β cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly. J Cell Biol. 1997; 137:131-140.
120. Fyrberg E, Fyrberg CC, Beall C, Saville DL. Drosophila melanogaster troponin-T mutations engender three distinct syndromes of myofibrillar abnormalities. J Mol Biol. 1990;216:657-675.
121. Lin D, Bobkova A, Homsher E, Tobacman LS. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest. 1996;97:2842-2848.
122. 2+ regulation of thin filament motility. Biochem Biophys Res Commun. 1997;236:760-764.
123. Golitsina N, An Y, Greenfield NJ, Thierfelder L, lizuka L, Seidman JG, Seidman CE, Lehrer SS, Hitchcock-DeGregori SE. Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function. Biochemistry. 1997;36: 4367-4642.
124. Fujita H, Sugiura S, Momomura S, Omata M, Sugi H, Sutoh K. Characterization of mutant myosins of dictostelium discoideum equivalent to human familial hypertrophic mutants: molecular force level of mutant myosins may have prognostic implication. J Clin Invest. 1997;99: 1010-1015.
125. Tohtong R, Yamashima H, Graham M, Haeberle J, Simcox A, Maughan D. Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain. Nature. 1995;374: 650-653.
126. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26: 1699-1708.
127. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain mutations. Circulation. 1994;89:22-32.
128. Spirito P, Seidman CE, Mckenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.
129. Charron P, Dubourg O, Desnos M, Bennaceur M, Carrier L, Camproux A-C, Isnard R, Hagège A, Langlard JM, Bonne G, Richard P, Hainque B, Bouhour J-B, Schwartz K, Komajda M. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to cardiac myosin-binding protein C gene. Circulation. 1998;97: 2230-2236.
130. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993;342:1085-1086.
131. Yonega K, Okamoto H, Machida M, Onozuka H, Noguchi M, Mikami T, Kawaguchi H, Muurakami M, Uede T, Kitabatake A. Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J. 1995;130:1089-1093.
132. Tesson F, Dufour C, Moolman JC, Carrier L, Al-Mahdawi S, Brink P, Komajda M, Guicheney P, Schwartz K, Feingold J. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol. 1997;29:831-838.
133. Charron P, Dubourg O, Desnos M, Isnard R, Hagège A, Millaire A, Carrier L, Bonne G, Tesson F, Richard P, Bouhour JB, Schwartz K, Komajda M. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation. 1997;96:214-219.
134. Clark CE, Henry WL, Epstein SE. Familial prevalence and genetic transmission of idiopathic subaortic stenosis. N Engl J Med. 1973;289: 709-714.
135. Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol. 1984;53: 1087-1094.
136. Greaves SC, Roche AHG, Neutze JM, Whitlock RML, Veale AMO. Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families. Br Heart J. 1987;58: 259-266.
137. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, Hanaoka F. Both hypertrophic and dilated cardiomyopathies are caused by mutation in the same gene, [delta]-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci U S A. 1997;94:13873-13878.
138. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998;280:750-752.
139. Jarcho JA, McKenna W, Pare JAP, Solomon SD, Holcombe RF, Dickie S, Levi T, Donis-Keller H, Seidman JG, Seidman CE. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med. 1989;321:1372-1378.
140. Watkins H, MacRae C, Thierfelder L, Chou YH, Frenneaux M, McKenna WJ, Seidman JG, Seidman CE. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet. 1993;3:333-337.
141. Thierfelder L, MacRae C, Watkins H, Tomfohde J, Williams M, McKenna WJ, Bohm K, Noeske G, Schlepper M, Bowcock A, Vosberg HP, Seidman JG, Seidman CE. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci U S A. 1993;90: 6270-6274.
142. Carrier L, Hengstenberg C, Beckmann JS, Guicheney P, Dufour C, Bercovici J, Dausse E, Berebbi-Bertrand I, Wisnewsky C, Pulvenis D, Fetler L, Vignal A, Weissenbach J, Hillaire D, Feingold J, Bouhour JB, Hagege A, Desnos M, Isnard R, Dubourg O, Komajda M, Schwartz K. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet. 1993;4:311-313.
143. Yamamoto K, Moos C. The C-proteins of rabbit red, white and cardiac muscles. J Biol Chem. 1983;258:8395-8401.
144. Sata M, Ikebe M. Functional analysis of the mutations in the human cardiac β-myosin that are responsible for familial hypertrophic cardiomyopathy. J Clin Invest. 1997;98:2866-2873.